Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis.

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 27842535)

Published in BMC Pulm Med on November 14, 2016

Authors

Paul K Drain¹^,2^,3^,4, Elena Losina⁵^,6^,7, Sharon M Coleman⁸, Janet Giddy⁹, Douglas Ross¹⁰, Jeffrey N Katz⁷, Ingrid V Bassett⁵^,11^,6

Author Affiliations

1: Department of Global Health, University of Washington, 325 Ninth Ave, UW Box 359927, Seattle, WA, 98104-2420, USA. pkdrain@uw.edu.
2: Department of Medicine, University of Washington, Seattle, WA, USA. pkdrain@uw.edu.
3: Department of Epidemiology, University of Washington, Seattle, WA, USA. pkdrain@uw.edu.
4: Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, USA. pkdrain@uw.edu.
5: Medical Practice Evaluation Center, Harvard Medical School, Boston, USA.
6: Division of General Internal Medicine, Harvard Medical School, Boston, USA.
7: Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
8: Boston University School of Public Health, Boston, USA.
9: Department of Medicine, McCord Hospital, Durban, South Africa.
10: Department of Medicine, St. Mary's Hospital, Durban, South Africa.
11: Division of Infectious Diseases, Harvard Medical School, Boston, USA.

Associated clinical trials:

Linkage and Retention: A Randomized Trial to Optimize HIV/TB Care in South Africa (Sizanani) | NCT01188941

Articles cited by this ↗

Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis (2011) 7.23

Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med (2011) 4.29

Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS (2009) 4.29

An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med (2010) 4.24

Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infect Dis (2012) 2.42

Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial. Lancet (2016) 1.71

Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study. AIDS (2010) 1.50

Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study. BMC Infect Dis (2014) 1.32

Defining the needs for next generation assays for tuberculosis. J Infect Dis (2015) 1.24

Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic. Clin Infect Dis (2012) 1.19

Pulmonary tuberculosis among patients visiting a voluntary confidential counseling and testing center, Cambodia. Int J Tuberc Lung Dis (2008) 1.12

Value of urine lipoarabinomannan grade and second test for optimizing clinic-based screening for HIV-associated pulmonary tuberculosis. J Acquir Immune Defic Syndr (2015) 1.10

Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysis. PLoS One (2013) 1.08

Inaccuracy of death certificate diagnosis of tuberculosis and potential underdiagnosis of TB in a region of high HIV prevalence. Clin Dev Immunol (2012) 0.99

A randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trial. BMC Infect Dis (2013) 0.98

A sensitive urinary lipoarabinomannan test for tuberculosis. PLoS One (2015) 0.96

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults. Cochrane Database Syst Rev (2016) 0.87

Articles by these authors ⇆

Clinic-Based Urinary Lipoarabinomannan as a Biomarker of Clinical Disease Severity and Mortality Among Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Infected Adults in South Africa. Open Forum Infect Dis (2017) 0.75